X4 Pharmaceuticals Growth Metrics (2018-2025) | XFOR

Growth Metrics Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 0.03M-1.40M0.46M
EBITDA Margin Growth (3y) 0.30M-0.24M-0.36M-0.35M
EBITDA Margin Growth (5y) -0.10M0.03M
EBITDA Margin (QoQ) 0.02M0.20M-0.60M-0.01M-0.03M0.03M0.04M-1.88M0.37M0.24M-0.13M-0.02M
EBIT Margin Growth (1y) 0.03M-1.40M0.46M
EBIT Margin Growth (3y) 0.30M-0.24M-0.36M-0.35M
EBIT Margin Growth (5y) -0.10M0.03M
EBIT Margin (QoQ) 0.02M0.20M-0.60M-0.01M-0.03M0.03M0.04M-1.88M0.37M0.24M-0.13M-0.02M
EBT Margin Growth (1y) -0.02M-1.74M0.49M
EBT Margin Growth (3y) 0.25M-0.24M-0.36M-0.38M
EBT Margin Growth (5y) -0.15M0.04M
EBT Margin (QoQ) 0.02M0.20M-0.61M-0.01M-0.02M0.04M-0.04M-2.27M0.39M0.27M-0.13M-0.04M
Enterprise Value Growth (1y) 65.19%-639.82%-670.91%-1,432.29%-415.96%-11.14%-16.47%37.62%0.09%8.24%13.98%-3.91%42.21%50.21%-4.58%-48.82%-40.61%-187.82%-64.68%18.49%35.24%-7.91%25.97%43.86%33.45%73.36%28.52%
Enterprise Value Growth (3y) -21.52%-96.14%-97.67%-114.95%-43.89%20.22%-1.57%1.19%6.71%-9.56%-14.00%-8.02%19.26%-15.64%-8.44%12.02%15.37%6.12%4.48%
Enterprise Value Growth (5y) -7.84%-60.99%-67.80%-64.51%-22.09%-9.54%-5.02%15.09%18.94%17.68%4.75%
Enterprise Value (QoQ) 80.30%21.61%16.74%-170.78%-318.60%18.31%-65.49%8.82%9.83%14.39%11.38%-46.04%17.18%19.75%-7.05%18.78%28.64%-68.57%-52.34%23.26%-46.06%3.55%24.60%39.03%-143.36%33.83%42.82%27.72%2.58%-77.54%
FCF Margin Growth (1y) 0.02M1.04M0.45M
FCF Margin Growth (3y) 0.29M-0.23M-0.35M-0.35M
FCF Margin Growth (5y) -0.13M0.05M
FCF Margin (QoQ) -0.02M0.11M-0.47M-0.02M-0.01M-0.02M0.07M0.59M0.41M0.20M-0.15M-0.01M
Gross Margin Growth (1y) 0.00M0.00M
Gross Margin (QoQ) 707.000.00M408.00-15.00-336.00
Interest Coverage Ratio Growth (1y) 27.64%31.38%57.26%41.85%30.74%18.56%1.27%-23.56%-11.11%1.62%14.70%-28.10%-15.72%-6.75%4.73%28.82%-13.43%-0.32%15.87%40.24%24.70%245.37%14.19%-16.02%78.44%-135.97%14.72%
Interest Coverage Ratio Growth (3y) 17.73%18.08%28.87%2.73%3.79%5.08%7.08%-4.05%-13.40%-1.75%11.91%18.32%0.39%52.64%11.73%20.98%43.10%19.35%14.93%
Interest Coverage Ratio Growth (5y) 6.08%10.05%22.01%17.10%5.33%26.56%10.35%4.82%25.03%11.24%12.93%
Interest Coverage Ratio (QoQ) -5.60%-51.22%40.89%23.34%-0.15%5.82%19.57%8.70%-17.76%-14.18%-0.65%17.91%-4.28%1.00%-51.15%25.84%3.81%11.65%-12.93%-18.19%14.93%25.91%19.78%-48.93%264.22%-143.74%-8.46%72.32%-173.93%-3.71%
Net Margin Growth (1y) -0.05M-1.74M0.49M
Net Margin Growth (3y) 0.25M-0.27M-0.36M-0.38M
Net Margin Growth (5y) -0.26M0.04M
Net Margin (QoQ) -0.07M0.22M-0.67M-0.03M-0.02M0.04M-0.04M-2.27M0.39M0.27M-0.13M-0.04M
Operating Margin Growth (1y) 0.03M-1.40M0.46M
Operating Margin Growth (3y) 0.30M-0.24M-0.36M-0.35M
Operating Margin Growth (5y) -0.10M0.03M
Operating Margin (QoQ) 0.02M0.20M-0.60M-0.01M-0.03M0.03M0.04M-1.88M0.37M0.24M-0.13M-0.02M
Return on Assets Growth (1y) 67.0061.005.002.00-9.00-15.00-12.00-19.00-26.00-36.00-55.00-39.005.0016.0016.0034.007.00-31.0099.0055.0040.00110.00-98.00-62.00
Return on Assets Growth (3y) 31.0010.00-62.00-56.00-31.00-35.00-51.00-25.00-15.00-50.0060.0050.0052.0095.0017.0027.00
Return on Assets Growth (5y) 43.00-5.0053.0033.0016.0044.00-50.00-31.00
Return on Assets (QoQ) 11.0052.001.002.005.00-3.00-3.00-9.00-1.000.00M-10.00-16.00-10.00-19.006.0028.001.00-19.0023.001.00-36.00110.00-20.00-14.0034.00-97.0016.00
Return on Capital Employed Growth (1y) 104.00134.009.001.00-10.00-18.00-13.00-20.00-30.00-42.00-80.00-70.003.0015.0052.0060.000.00M-29.0066.0057.0050.00101.00-98.00-74.00
Return on Capital Employed Growth (3y) 64.0074.00-84.00-90.00-37.00-45.00-41.00-30.00-27.00-56.0038.0047.0053.0087.0020.0044.00
Return on Capital Employed Growth (5y) 67.0060.0034.0027.0013.0027.00-73.00-47.00
Return on Capital Employed (QoQ) -23.00121.005.002.006.00-4.00-4.00-9.00-1.001.00-11.00-19.00-13.00-37.00-1.0055.00-1.000.00M7.00-5.00-31.0095.00-2.00-12.0021.00-104.0023.00
Return on Equity Growth (1y) -92.00-186.0016.001.00-26.00-36.00-28.00-42.00-57.00-83.00-157.00-108.00-5.009.0016.0042.00-32.00-342.00256.00143.0079.00559.00-795.00-268.00
Return on Equity Growth (3y) -175.00-305.00-169.00-149.00-87.00-110.00-170.00-108.00-94.00-416.00114.0077.0042.00226.00-523.00-83.00
Return on Equity Growth (5y) -212.00-638.00102.0036.00-41.00108.00-709.00-234.00
Return on Equity (QoQ) 102.00-209.008.007.008.00-6.00-7.00-20.00-2.001.00-21.00-35.00-28.00-73.0028.0068.00-14.00-66.0054.00-6.00-324.00531.00-59.00-70.00156.00-823.00468.00
Return on Invested Capital Growth (1y) -20.00-17.00-23.00-31.00-43.00-69.00-49.00-1.00-1.0015.0019.00-7.00-42.0093.0080.0062.00134.00-104.00-75.00
Return on Invested Capital Growth (3y) -65.00-71.00-53.00-40.00-87.0039.0050.0054.0090.004.0024.00
Return on Invested Capital Growth (5y) 27.00-81.00-49.00
Return on Invested Capital (QoQ) -3.00-5.00-11.00-1.000.00M-11.00-19.00-13.00-26.008.0029.00-13.00-9.0013.003.00-48.00126.00-1.00-15.0023.00-112.0028.00
Return on Sales Growth (1y) -0.00M-0.01M-0.01M704.00-600.00-384.00-240.000.00M0.00M0.01M0.01M-0.01M-0.01M-0.02M0.00M
Return on Sales Growth (3y) 0.00M0.00M0.00M0.00M0.01M0.01M0.01M-0.00M-0.00M-0.00M
Return on Sales Growth (5y) -0.00M109.00-906.000.01M0.02M-0.01M372.00523.00130.00
Return on Sales (QoQ) 203.000.00M-0.01M-839.00-153.00-207.00-0.00M9.00-252.00-95.00-190.00424.00-378.000.00M946.000.00M-0.02M0.00M0.00M-0.00M-385.00